Stephen J. Russell

Mayo Clinic — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

106h-index43.4kcitations854works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(356), Multiple Myeloma Research and Treatments(179), Amyloidosis: Diagnosis, Treatment, Outcomes(125), Virology and Viral Diseases(112), Animal Virus Infections Studies(98)

Publications851 total

Lentiviral vectors engineered for direct In Vivo delivery to resting T cells
Blood·2025Open Access
Intravenously administered LV-169 delivers a functional BCMA-CAR transgene to niche-resident T cells and leads to elimination of disseminated myeloma in MHC-deficient NSG mice
Blood·2025· 2 citedOpen Access
Cancer viroimmunotherapy platforms based on varicella-zoster virus and cytomegalovirus
Molecular Therapy·2025Open Access
Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care
Veterinary Sciences·2025Open Access
Abstract 940: Harnessing oncolytic virus VSV and combination therapy to advance treatments for relapsed refractory multiple myeloma using Vk*MYC models
Cancer Research·2025
MP15-16 NEOADJUVANT INTRAVESICAL ONCOLYTIC MEASLES IMMUNOTHERAPY FOR BLADDER CANCER
The Journal of Urology·2025
List of contributors
Elsevier eBooks·2025
Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug-controllable interleukin 12
Cell Reports Medicine·2024· 4 citedOpen Access
P090 Ten year results of a phase i trial of oncolytic adenovirus-mediated sodium Iodide Symporter (nis) gene delivery in locally recurrent prostate cancer following primary radiotherapy
European Urology Open Science·2024Open Access
Development and Evaluation of Efficient Field Deployable Sample Preparation: Fit-For-Purpose Representative pXRF
Sampling Science & Technology·2024Open Access
Smoldering oncolysis by foamy virus carrying CD19 as a CAR target escapes CAR T detection by genomic modification
Molecular Therapy Oncology·2024· 3 citedOpen Access
Abstract 7239: Eradication of B cell lymphoma in a mouse model through <i>in vivo</i> transduction of T cells with an aCD19-CAR utilizing a CD3-targeted lentiviral vector
Cancer Research·2024
Oncolytic varicella-zoster virus engineered with ORF8 deletion and armed with drug-controllable interleukin-12
Journal for ImmunoTherapy of Cancer·2024· 4 citedOpen Access
Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma.
Journal of Clinical Oncology·2024· 1 cited
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
mBio·2024· 3 citedOpen Access
Phase 1-2 trial of vesicular stomatitis virus expressing human interferon-[beta] and NIS (VSV-IFN[beta]-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma
Endocrine Abstracts·2023· 1 cited
Abstract A024: Systemic administration of CD3-redirected lentiviral vector efficiently targets CD19-CAR delivery to human T cells in vivo
Cancer Immunology Research·2023
Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses
Molecular Therapy·2023· 5 citedOpen Access
Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients with Relapsed or Refractory Multiple Myeloma, Lymphomas, or Histiocytic/Dendritic Cell Neoplasms
Blood·2023
In Vivo Generation of Functional CD19 CAR-T Cells Using a Serum-Stable CD3-Targeted Lentiviral Vector
Blood·2023· 3 cited
page 1 of 43Next →

Frequent Co-authors

S. Vincent Rajkumar(25), Angela Dispenzieri(25), Morie A. Gertz(25), Martha Q. Lacy(24), Shaji Kumar(23), Suzanne R. Hayman(23), John A. Lust(22), Robert A. Kyle(21), Steven R. Zeldenrust(20), Philip R. Greipp(20), David Dingli(19), Francis K. Buadi(17), Rafaël Fonseca(12), Thomas E. Witzig(12), Nelson Leung(9), Vivek Roy(9), Kah-Whye Peng(8), P. Leif Bergsagel(7), Joseph Mıkhael(6), Craig B. Reeder(6)